Lutecia Care

Who owns Lutecia Care?

Lutecia Care is currently owned by Raise through RAISE Invest (2014 vintage), since 2024.

Hand-verified · updated 2026-06-01

About Lutecia Care

Lutecia Care is a Paris-based healthcare group that consolidates independent nuclear medicine centers across France, providing medical, regulatory and operational support while leaving clinical governance in the hands of practising physicians. It addresses a fragmented segment of French medical imaging, where nuclear medicine centers, specialised in PET/CT and molecular imaging, typically operate as small, geographically dispersed and largely isolated units. The model pairs central management of administrative, financial and regulatory functions with a partnership structure designed to keep doctors as shareholders in their own centers and to preserve each site's existing methods and local footprint. According to the company and its backers, it has positioned itself as one of the first institutional consolidators in a sector that has seen little aggregation to date.

Ownership journey

Lutecia Care was founded in 2023 by Gregory Hiely, a specialist healthcare investor who serves as chairman and chief executive, and Dr Erwann Gabiache, a nuclear physician who acts as its medical and scientific director, around a shared thesis that France's autonomous nuclear medicine centers would gain from pooled support without surrendering their independence. In 2024 the company secured backing from RAISE, investing through its RAISE Invest fund, which became its principal financial sponsor. RAISE Invest is listed as a current shareholder and no exit or secondary transaction has been recorded. Financial databases place the total capital raised at roughly USD 11.5 million, deployed to seed the group's expansion.

Under PE ownership

Since the RAISE Invest backing in 2024, Lutecia Care has used its funding to begin building a national platform, acquiring within its first year a regional group of three nuclear medicine sites as its first anchor. The capital supports a buy-and-build strategy aimed at bringing further independent centers into the group while standardising back-office, regulatory and financial management across them. Consistent with its stated governance model, the company has extended physician ownership, and in 2026 it supported seven younger doctors in becoming full partners in their centers. Management has framed continued center additions as central to its plan, positioning Lutecia Care as a consolidating operator in French nuclear medicine.